A new nature medicine review is listing clinical trials targeting Toll-like receptors. These include 3 preclinical studies all using cpG-ODNs against TLR9 by Dynavax Astra-Zeneca, Coley / Sanofi-Aventis and Idera / Novartis. Lets wait and see…
A new nature medicine review is listing clinical trials targeting Toll-like receptors. These include 3 preclinical studies all using cpG-ODNs against TLR9 by Dynavax Astra-Zeneca, Coley / Sanofi-Aventis and Idera / Novartis. Lets wait and see…
